2m 2m 2m 2m 2m 2m 2m
LUNAI BIOWORKS (LNAI)
NASDAQ
$2.82-$0.17 (-5.54%)
Price as of Jun 03, 2026 6:56 PM EDT- $14.0MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
LUNAI BIOWORKS (LNAI)
$2.82-$0.17 (-5.54%)
Annual
Quarterly
06/30/2025 | 06/30/2024 | 06/30/2023 | 06/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | -126,620 N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 +100.00% | -126,620 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -537,428 -80.16% | -2.7M -34.97% | -4.2M -50.25% | -8.4M -46.11% | |
Depreciation and Amortization Expense | 129,095 +5.94% | 121,859 +7.37% | 113,496 -8.17% | 123,590 +0.05% | |
Total Operating Expenses | 189.0M +131.46% | 81.6M +111.74% | 38.6M -66.78% | 116.1M +396.03% | |
Operating Profit | -189.0M +131.46% | -81.6M +111.74% | -38.6M -66.78% | -116.1M +396.03% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | 122,041 +826.03% | |
Interest Expense | N/A N/A | -6,316 -95.01% | -126,620 -66.04% | -372,844 -1.78% | |
Interest Income and Expense and Net | 0 +100.00% | -6,316 -95.01% | -126,620 -49.51% | -250,803 -31.55% | |
Total Nonoperating Income and Expense | 11.0M +261.47% | -6.8M +502.09% | -1.1M -142.60% | 2.6M +176.76% | |
Income before Taxes | -189.0M +131.46% | -81.6M +105.72% | -39.7M -65.02% | -113.4M +322.49% | |
Income Taxes | 1,474 N/A | 0 N/A | N/A N/A | 34 +100.03% | |
Extraordinary Items | 0 N/A | 0 -100.00% | 19.0M -79.67% | 93.3M N/A | |
Net Income | -178.0M +101.31% | -88.4M +122.82% | -39.7M -65.02% | -113.4M +324.47% | |
Net Income from Continuing Operations Applicable to Common | -178.0M +101.31% | -88.4M +122.82% | -39.7M -65.02% | -113.4M +324.47% | |
Basic EPS and Net Income | -1.08 +18.68% | -0.91 +28.17% | -0.71 N/A | N/A N/A | |
Diluted EPS and Net Income | -1.08 +18.68% | -0.91 +28.17% | -0.71 N/A | N/A N/A | |
Basic Weighted Average Shares | 165.1M +69.27% | 97.5M +73.31% | 56.3M N/A | N/A N/A | |
Diluted Weighted Average Shares | 165.1M +69.27% | 97.5M +73.31% | 56.3M N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 92,700 -57.95% | 220,467 -88.24% | 1.9M -79.56% | 9.2M -55.61% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 92,700 -57.95% | 220,467 -88.24% | 1.9M -79.56% | 9.2M -55.61% | |
Total Current Assets | 1.0M -47.61% | 2.0M -22.13% | 2.6M -73.18% | 9.6M -54.23% | |
Accumulated Depreciation | 702,180 +21.41% | 578,340 +24.43% | 464,799 +30.02% | 357,478 +37.14% | |
Property and Plant and Equipment and Net | 367,843 -23.70% | 482,121 -5.28% | 508,989 -13.22% | 586,536 -18.46% | |
Total Long-Term Assets | 6.8M -95.76% | 160.6M +190.89% | 55.2M -25.85% | 74.5M -55.66% | |
Total Assets | 8.2M -94.95% | 163.1M +179.81% | 58.3M -31.11% | 84.6M -55.36% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 4.6M +285.41% | 1.2M N/A | |
Total Current Liabilities | 29.2M -3.81% | 30.3M +174.97% | 11.0M +70.88% | 6.5M +242.06% | |
Total Long-Term Debt | 3.8M +1,461.44% | 245,000 -79.58% | 1.2M -73.78% | 4.6M -20.80% | |
Total Long-Term Liabilities | 424,547 -49.60% | 842,389 +8.61% | 775,587 -86.06% | 5.6M -62.77% | |
Total Liabilities | 29.6M -5.04% | 31.2M +164.03% | 11.8M -1.79% | 12.0M +284.41% | |
Retained Earnings | -510.5M +53.54% | -332.5M +36.24% | -244.0M +19.42% | -204.3M +124.77% | |
Total Stockholders Equity | N/A N/A | 132.0M +183.81% | 46.5M -35.96% | 72.6M -58.42% | |
Total Shares Outstanding | 177.4M +11.95% | 158.5M +148.76% | 63.7M +20.17% | 53.0M +1.51% | |
Cash Flow | |||||
Cash from Operating Activities | -7.9M -28.23% | -11.0M -6.82% | -11.8M -25.16% | -15.7M -23.67% | |
Capital Expenditures | N/A N/A | 70,430 +136.55% | 29,774 +477.46% | 5,156 -89.45% | |
Cash from Investing Activities | -500,000 -60.32% | -1.3M +4,132.48% | -29,774 +477.46% | -5,156 -89.45% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.4M -20.30% | 10.5M +132.94% | 4.5M +6.23% | 4.3M -86.96% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | 30,450.87% N/A | N/A N/A | |
Return on Assets | -207.76% +160.13% | -79.87% +43.83% | -55.53% -32.88% | -82.73% +469.14% | |
Return on Equity | N/A N/A | -99.09% +48.72% | -66.63% -27.38% | -91.74% +485.23% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 0.04 -45.52% | 0.07 -71.68% | 0.23 -84.31% | 1.48 -86.62% | |
Cash Ratio | 0.003 -56.16% | 0.007 -95.71% | 0.17 -88.04% | 1.42 -87.02% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.13 +57.41% | 0.08 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.10 +46.27% | 0.07 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow